Liver Institute NW — Seattle, Washington

Liver Institute NW is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Liver Institute NW has participated in 2 clinical trials.

Therapeutic areas: Non-alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes.

Sponsors: Novo Nordisk A/S, HighTide Biopharma Pty Ltd.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Liver Institute NW?

Liver Institute NW has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Liver Institute NW conducted?

Liver Institute NW has 2 clinical trials on record. Their work covers Non-alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes.

Is Liver Institute NW accredited by Crixeo Health?

Liver Institute NW has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Liver Institute NW?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.